TICKERNOMICS Sign up
Last Update: 2024-12-27 15:29:50
BIO-PATH HOLDINGS INC. ( BPTH ) https://www.biopathholdings.com
1.35USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-86.20%
BPTH
SPY
32.66%
-98.40%
BPTH
SPY
108.59%
-99.16%
BPTH
SPY
302.52%
-99.99%
BPTH
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
4.07
3.60
1.66
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.39
11.28
-5.72
-236.35
0.00
-0.30
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-1348.54
-17.15
-1081.75
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
6.0496
-147.78
-153.85
0.47
Other Earnings and Cash Flow Stats:
BIO-PATH HOLDINGS INC. ( BPTH ) Net Income TTM ($MM) is -10.51
BIO-PATH HOLDINGS INC. ( BPTH ) Operating Income TTM ($MM) is -12.40
BIO-PATH HOLDINGS INC. ( BPTH ) Owners' Earnings Annual ($MM) is -11.62
BIO-PATH HOLDINGS INC. ( BPTH ) Current Price to Owners' Earnings ratio is -0.42
BIO-PATH HOLDINGS INC. ( BPTH ) EBITDA TTM ($MM) is -12.25
BIO-PATH HOLDINGS INC. ( BPTH ) EBITDA Margin is -1081.75%
Capital Allocation:
BIO-PATH HOLDINGS INC. ( BPTH ) has paid 0.00 dividends per share and bought back -2.51435 million shares in the past 12 months
BIO-PATH HOLDINGS INC. ( BPTH ) has reduced its debt by 0.056 million USD in the last 12 months
Capital Structure:
BIO-PATH HOLDINGS INC. ( BPTH ) Interest-bearing Debt ($MM) as of last quarter is 0
BIO-PATH HOLDINGS INC. ( BPTH ) Annual Working Capital Investments ($MM) are 0
BIO-PATH HOLDINGS INC. ( BPTH ) Book Value ($MM) as of last quarter is -1
BIO-PATH HOLDINGS INC. ( BPTH ) Debt/Capital as of last quarter is -4%
Other Balance Sheet Stats:
BIO-PATH HOLDINGS INC. ( BPTH ) has 0 million in cash on hand as of last quarter
BIO-PATH HOLDINGS INC. ( BPTH ) has 3 million of liabilities due within 12 months, and long term debt 0 as of last quarter
BIO-PATH HOLDINGS INC. ( BPTH ) has 3 common shares outstanding as of last quarter
BIO-PATH HOLDINGS INC. ( BPTH ) has 0 million USD of preferred stock value
Academic Scores:
BIO-PATH HOLDINGS INC. ( BPTH ) Altman Z-Score is -66.70 as of last quarter
BIO-PATH HOLDINGS INC. ( BPTH ) Piotroski Score is 1.00 as of last quarter
Corporate Governance:
BIO-PATH HOLDINGS INC. ( BPTH ) largest shareholder is Virtu Financial LLC owning 12325 shares at 0.02 ($MM) value
Sherwood Aline(an insider) Bought 10000 shares of BIO-PATH HOLDINGS INC. ( BPTH ) for the amount of $0.00 on 2022-03-31
0.04% of BIO-PATH HOLDINGS INC. ( BPTH ) is held by insiders, and 1.08% is held by institutions
BIO-PATH HOLDINGS INC. ( BPTH ) went public on 2008-03-04
Other BIO-PATH HOLDINGS INC. ( BPTH ) financial metrics:
FCF:-10.57
Unlevered Free Cash Flow:-12.78
EPS:-2.80
Operating Margin:-1348.54
Gross Profit Margin:-17.15
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:1188.20
Beta:0.47
Buffet's Owners Earnings:-11.62
Price to Owner's Earnings:-0.42
About BIO-PATH HOLDINGS INC. ( BPTH ) :
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and prexigebersen-A for various solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.